Yael Sharon

ORCID: 0000-0003-1474-218X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Ocular Diseases and Behçet’s Syndrome
  • Retinal and Optic Conditions
  • Retinal Diseases and Treatments
  • Ocular Surface and Contact Lens
  • Glaucoma and retinal disorders
  • Urticaria and Related Conditions
  • Cerebral Venous Sinus Thrombosis
  • Pituitary Gland Disorders and Treatments
  • Systemic Lupus Erythematosus Research
  • Autoimmune Bullous Skin Diseases
  • Coagulation, Bradykinin, Polyphosphates, and Angioedema
  • Ocular Infections and Treatments
  • Drug-Induced Ocular Toxicity
  • Ophthalmology and Eye Disorders
  • Ocular Oncology and Treatments
  • MicroRNA in disease regulation
  • Autoimmune and Inflammatory Disorders
  • Ophthalmology and Visual Health Research
  • Immune Response and Inflammation
  • Pregnancy and Medication Impact
  • Genetics and Physical Performance
  • Genetic Associations and Epidemiology
  • Bartonella species infections research
  • Whipple's Disease and Interleukins
  • Syphilis Diagnosis and Treatment

Rabin Medical Center
2016-2025

Tel Aviv University
2021-2025

Herzliya Medical Center
2024

Ariel University
2013

Data on the risk of stroke in patients with hyperprolactinemia are limited. This study aimed to evaluate association between and ischemic a large cohort identify predictors this population. was retrospective comparing incidence dopamine agonist-treated matched controls 1:5 ratio. The primary outcome diagnosis stroke. included 2440 DA-treated (mean age ± SD: 38.42 14.57 years, 60.2% women) 12,022 38.15 14.36 60.8% women). Ischemic occurred 195 (8.0%) 747 (6.21%) (adjusted HR 1.24, 95% CI...

10.1111/jne.13494 article EN Journal of Neuroendocrinology 2025-02-09

Purpose To evaluate the rate of ocular complications for pediatric uveitic patients, treated with anti-tumor necrosis factor-alpha (TNF-α) agents.

10.1080/09273948.2025.2465776 article EN Ocular Immunology and Inflammation 2025-02-11

The FTO A/T polymorphism (rs9939609) is a strong candidate to influence obesity-related traits. Elite athletes from many different sporting disciplines are characterized by low body fat. Therefore, the aim of this study was assess whether athletic status associated with polymorphism.A large cohort European Caucasians Poland, Russia and Spain were tested examine association between status. A total 551 divided type sport (endurance athletes, n = 266 vs. sprint/power 285) as well level...

10.1371/journal.pone.0060570 article EN cc-by PLoS ONE 2013-04-03

Purpose: To study the prevalence and time of onset ocular complications in intermediate uveitis (IU) to assess their effects on visual outcome short-term long-term follow-up.Methods: A retrospective cohort patients with IU who had a minimal follow-up one year.Results: 96 (174 eyes, 70% females) were included mean age at presentation 30 years. Children constituted 38% all patients. Mean follow- up was 64.9 months. Pars planitis most common form followed by sarcoidosis multiple sclerosis....

10.1080/09273948.2017.1420203 article EN Ocular Immunology and Inflammation 2018-01-25

Purpose: To study the long-term clinical outcomes of uveitic glaucoma and to identify risk factors for progression.Methods: Retrospective patients in two tertiary medical centers 2003–2015. Patient- disease-related data was retrieved. Clinical parameters visual fields measured at predetermined time points were recorded. Outcome measures included maintaining intraocular pressure ≤21 mmHg preserving fields.Results: Included 34 (53 eyes), with a mean follow-up 7 years. Idiopathic anterior...

10.1080/09273948.2016.1255341 article EN Ocular Immunology and Inflammation 2016-12-12

Behçet disease (BD) is a multisystemic that commonly involves the eyes. Although it affects patients in all age groups, data on ocular by of onset are limited. This retrospective, multicenter study aimed to compare epidemiology, systemic and manifestations, treatments outcomes between three groups: juvenile (<18 years), adult (18–39 years) late (≥40 onset. The included 175 BD (303 eyes) from Israel Palestine: juvenile-onset (n = 25, 14.3%), adult-onset 120, 68.6%) late-onset 30, 17.1%)....

10.3390/biomedicines11020624 article EN cc-by Biomedicines 2023-02-19

Abstract Purpose The literature on retinal vascular occlusions in Behçet disease (BD) patients is limited. aim of this study to thoroughly investigate among ocular BD patients. Methods Retrospective, multicentre case–control study. Three‐hundred and three eyes 175 with BD, from 13 hospitals Israel Palestine, were included. Patients assigned into two groups according the presence occlusion. Epidemiology, systemic manifestations, treatments outcomes compared between risk factors for...

10.1111/aos.15645 article EN Acta Ophthalmologica 2023-02-07

The purpose of our study is to report experience with the use certolizumab pegol in patients refractory non-infectious uveitis.We present a case series three uveitis, treated twice-monthly subcutaneous pegol. All had different types uveitis and underlying etiologies. previously failed various immunomodulatory therapies and/or were intolerant at least one tumor necrosis factor (TNF) inhibitor agent. Following initiation therapy pegol, all showed significant clinical improvement their ocular...

10.1016/j.ajoc.2020.100633 article EN cc-by-nc-nd American Journal of Ophthalmology Case Reports 2020-02-27

Abstract Purpose Glaucoma incidence in patients with endogenous Cushing's syndrome (CS) has never been established. We aim to assess the risk for glaucoma among CS compared controls and determine age of disease onset. Methods A nationwide retrospective matched‐cohort study diagnosed between 2000 2023. Patients were matched a 1:5 ratio, control group individually age, sex, socioeconomic status body mass index. Main outcomes Results total 609 [396 women (65%); mean 48.1 ± 17 years] included...

10.1111/aos.16787 article EN cc-by-nc-nd Acta Ophthalmologica 2024-11-05

To describe the potential role of adrenocorticotropic hormone (ACTH) gel treatment in patients with chronic non-infectious uveitis. We report clinical course three bilateral, anterior and intermediate uveitis, treated ACTH for ≥12 months. All had steroid-dependent ocular inflammation subsequent development complications. Twice-weekly subcutaneous 80 unit/day was administered, outcome measures were observed. After a mean period 14 months, all demonstrated significant improvement disease...

10.1016/j.ajoc.2019.100502 article EN cc-by-nc-nd American Journal of Ophthalmology Case Reports 2019-06-22

To report the clinical outcome of a patient with ocular cicatricial pemphigoid, treated adrenocorticotropic hormone gel.A 75-year-old female biopsy proven pemphigoid (OCP) presented bilateral conjunctival inflammation, fornix shortening, subepithelial fibrosis and corneal scarring. The was previously topical steroids, cyclosporine lubricating drops, had undergone several amniotic membrane transplants due to recurrent erosions. Once OCP diagnosis established, started on oral corticosteroids...

10.1016/j.ajoc.2018.03.018 article EN cc-by-nc-nd American Journal of Ophthalmology Case Reports 2018-03-21

Purpose: The aim of this study is to compare the length time from uneventful cataract surgery using one two common posterior chamber intraocular lenses (IOLs) (hydrophilic versus hydrophobic acrylic) laser capsulotomy. Materials and Methods: Retrospective analysis all patients who underwent neodymium: yttrium-aluminum-garnet capsulotomy between 2011 2014 following phacoemulsification at a tertiary university-affiliated medical center. Medical records were reviewed for demographics, ocular...

10.4103/ijo.ijo_933_16 article EN cc-by-nc-sa Indian Journal of Ophthalmology 2017-01-01

Purpose Uveitis associated with juvenile idiopathic arthritis (JIA-U) is a clinically silent vision-impairing disease. Early detection and aggressive treatment are crucial for optimal visual outcome. Alterations in levels of microRNAs (miRNAs) characteristic autoimmune diseases. The present clinical study sought to explore the expression miRNAs JIA-U their potential role as predictive biomarker.

10.1080/09273948.2024.2428417 article EN cc-by-nc-nd Ocular Immunology and Inflammation 2024-11-19

To examine the safety and efficacy of combined treatment with topical ivermectin 1% intense pulsed light (IPL) for dry eye disease (DED) secondary to demodex blepharitis.

10.1097/ico.0000000000003774 article EN Cornea 2024-12-03
Coming Soon ...